A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.

@article{Niesen2016ANF,
  title={A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.},
  author={J. Niesen and Grit Hehmann-Titt and Mira Woitok and Rolf Fendel and S. Barth and R. Fischer and C. Stein},
  journal={Cancer letters},
  year={2016},
  volume={374 2},
  pages={
          229-40
        }
}
  • J. Niesen, Grit Hehmann-Titt, +4 authors C. Stein
  • Published 2016
  • Biology, Medicine
  • Cancer letters
  • Human cytolytic fusion proteins (hCFPs) offer a promising immunotherapeutic approach for the treatment of solid tumors, avoiding the immunogenicity and undesirable side-effects caused by immunotoxins derived from plants or bacteria. The well-characterized human serine protease granzyme B has already been used as a therapeutic pro-apoptotic effector domain. We therefore developed a novel recombinant hCFP (GbR201K-scFv1711) consisting of an epidermal growth factor receptor-specific human antibody… CONTINUE READING
    24 Citations
    Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B
    • 1
    Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13–ETA′ and the bispecific scFv [13xds16]
    • 5
    A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors
    Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation
    • 8
    • PDF
    CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL
    • 11
    • Highly Influenced
    • PDF

    References

    SHOWING 1-10 OF 74 REFERENCES
    Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition
    • 59
    • Highly Influential
    • PDF
    Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
    • 87
    • PDF
    Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities
    • 34